StonvexLoading…
StonvexStonvexStonvexCore line items from MDIA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $31.39M | $133.34M | $94.67M | $59.27M |
Operating Income | $-7.53M | $-24.76M | $-18.56M | $-11.47M |
Net Income | $-9.37M | $-66.22M | $-33.89M | $-7.39M |
EPS (Diluted) | $-0.11 | $-0.84 | $-0.44 | $-0.23 |
Total Assets | $274.90M | $291.06M | $319.39M | $315.15M |
Total Liabilities | $239.05M | $244.74M | $232.73M | $217.90M |
Cash & Equivalents | $3.11M | $5.11M | $6.25M | $2.94M |
Free Cash Flow OCF − CapEx | $-2.16M | $1.20M | $1.66M | $-1.17M |
Shares Outstanding | 81.67M | 79.39M | 78.63M | 77.10M |